
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
[ Fri, Sep 20th 2024 ]: WOPRAI
Yi Chen Reiterated (ANGO) at Strong Buy and Held Target at $14 on, Sep 20th, 2024


🞛 This publication is a summary or evaluation of another publication
Yi Chen of HC Wainwright & Co., Reiterated "AngioDynamics, Inc." (ANGO) at Strong Buy and Held Target at $14 on, Sep 20th, 2024.
Yi has made no other calls on ANGO in the last 4 months.
There is 1 other peer that has a rating on ANGO. Out of the 1 peers that are also analyzing ANGO, 0 agree with Yi's Rating of Hold.
This is the rating of the analyst that currently disagrees with Yi
- William Plovanic of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $13 on, Wednesday, July 17th, 2024